← Back to Search

Standard vs. Telemedicine Surveillance for Head and Neck Cancer

N/A
Recruiting
Led By Kaveh Zakeri, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Post-treatment diagnostic imaging with either CT or MRI (recommended but not required)
No evidence of disease on post-treatment PET/CT within 9 months of completing radiation therapy. No evidence of disease is a consensus determination by the patient's radiation, medical, and surgical oncologist. If the first PET/CT is equivocal, then a second PET/CT can be obtained within 9 months of completing radiation therapy.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will compare standard surveillance with telemedicine surveillance for people with HPV-associated head and neck cancer. Quality of life, health outcomes, and expenses will be compared to determine which approach is better.

Who is the study for?
This trial is for adults over 18 who've had HPV-related squamous cell carcinoma in the oropharynx, are now disease-free after treatment, and can give informed consent. They should be able to speak and read English fluently. Those treated more than 9 months ago or with incomplete response/recurrent disease aren't eligible.Check my eligibility
What is being tested?
The study compares two ways of monitoring patients after treating HPV-associated head and neck cancer: standard in-person check-ups versus telemedicine (remote) check-ups. It will assess quality of life, health outcomes, costs involved, and satisfaction levels with remote surveillance.See study design
What are the potential side effects?
Since this trial involves surveillance methods rather than medication or invasive procedures, there are no direct side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I may have had a CT or MRI scan after treatment.
Select...
My scans show no cancer signs after radiation, confirmed by my cancer doctors.
Select...
I can care for myself but may not be able to do heavy physical work.
Select...
My cancer is HPV-related and located in my throat area.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Progression-Free Survival (PFS)
Secondary outcome measures
Locoregional recurrence (LRR)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemedicine surveillance (tele-surveillance)Experimental Treatment2 Interventions
Tele-surveillance involves the participant staying at home while their healthcare providers follow their condition and give them the care they need. They can communicate with their healthcare team through face-to-face video conferencing on their desktop computer, laptop, smart phone, or tablet. They can also communicate with their healthcare team by phone.
Group II: Standard surveillanceActive Control2 Interventions
This surveillance approach involves the participant coming to the clinic for in-person follow-up visits and having routine endoscopy and cancer imaging procedures as needed

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,931 Previous Clinical Trials
597,647 Total Patients Enrolled
Kaveh Zakeri, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
2 Previous Clinical Trials
76 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still being accepted for this investigation?

"Affirmative. Clinicaltrials.gov reveals that recruitment for this medical experiment, which was first published on September 1st 2021, is still ongoing. The trial requires 160 participants and they must be located at a single clinical site."

Answered by AI

How many subjects are currently receiving the experimental treatment in this trial?

"Indeed, according to the clinicaltrials.gov website, this investigation is still recruiting candidates. The trial was published on September 1st 2021 and its records were last updated on August 17th 2022. A total of 160 individuals are needed at a single site for the study's completion."

Answered by AI
~21 spots leftby Sep 2025